NCT06457919: A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 50 planned
- Started
- 4 Jun 2024
- Primary completion
- Jun 2027
- Arms
- Tinengotinib with abiraterone acetate/prednisone
- Results
- None posted
- 4 Jun 2024: Trial started
- 13 Jun 2024: Trial registered